IRIS - Res&Arch Institutional Research Information System - Research & Archive

LIBERATI, Anna Marina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.580
EU - Europa 9.214
AS - Asia 8.136
SA - Sud America 2.009
Continente sconosciuto - Info sul continente non disponibili 1.289
AF - Africa 238
OC - Oceania 36
Totale 32.502
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.302
SG - Singapore 3.812
IE - Irlanda 1.700
BR - Brasile 1.584
RU - Federazione Russa 1.499
UA - Ucraina 1.403
IT - Italia 1.221
VN - Vietnam 1.127
SE - Svezia 1.033
HK - Hong Kong 983
CN - Cina 955
DE - Germania 584
FR - Francia 556
FI - Finlandia 544
GB - Regno Unito 233
IN - India 201
BD - Bangladesh 192
AR - Argentina 131
KR - Corea 131
TR - Turchia 117
CA - Canada 108
IQ - Iraq 101
AT - Austria 95
MX - Messico 95
PK - Pakistan 72
UZ - Uzbekistan 70
CH - Svizzera 67
ZA - Sudafrica 66
EC - Ecuador 65
CO - Colombia 60
ID - Indonesia 57
PL - Polonia 54
NL - Olanda 50
CL - Cile 45
VE - Venezuela 43
MA - Marocco 42
PH - Filippine 41
SA - Arabia Saudita 39
JP - Giappone 38
ES - Italia 34
AU - Australia 33
PY - Paraguay 29
TN - Tunisia 28
LB - Libano 27
PE - Perù 27
RO - Romania 27
MY - Malesia 23
KE - Kenya 22
GR - Grecia 19
CZ - Repubblica Ceca 18
EU - Europa 18
BE - Belgio 17
BO - Bolivia 17
JM - Giamaica 17
AE - Emirati Arabi Uniti 15
EG - Egitto 15
NP - Nepal 15
ET - Etiopia 14
IL - Israele 14
JO - Giordania 14
DZ - Algeria 11
HN - Honduras 10
KZ - Kazakistan 10
PS - Palestinian Territory 9
AZ - Azerbaigian 8
OM - Oman 8
TH - Thailandia 8
AL - Albania 7
CR - Costa Rica 7
MD - Moldavia 7
UY - Uruguay 7
BB - Barbados 6
DO - Repubblica Dominicana 6
RS - Serbia 6
SN - Senegal 6
SY - Repubblica araba siriana 6
TW - Taiwan 6
BG - Bulgaria 5
KG - Kirghizistan 5
LT - Lituania 5
NI - Nicaragua 5
PA - Panama 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
XK - ???statistics.table.value.countryCode.XK??? 5
AO - Angola 4
BA - Bosnia-Erzegovina 4
GT - Guatemala 4
BH - Bahrain 3
CI - Costa d'Avorio 3
GA - Gabon 3
GE - Georgia 3
IR - Iran 3
KH - Cambogia 3
KW - Kuwait 3
ML - Mali 3
MM - Myanmar 3
QA - Qatar 3
SC - Seychelles 3
Totale 31.177
Salva come PNG Salva come JPEG
Città #
Singapore 2.502
Dublin 1.697
Chandler 1.371
San Mateo 1.079
Hong Kong 972
San Jose 884
Dong Ket 667
Ashburn 640
Boardman 627
Santa Clara 546
Moscow 528
Altamura 491
Medford 480
Princeton 478
Wilmington 408
Lauterbourg 406
Lawrence 372
Andover 351
Jacksonville 318
Perugia 254
Ann Arbor 210
Ho Chi Minh City 165
Beijing 153
Des Moines 145
The Dalles 143
Saint Petersburg 136
Seoul 123
São Paulo 121
Los Angeles 112
Norwalk 95
Hanoi 91
New York 87
Falls Church 69
Helsinki 66
San Paolo di Civitate 64
Munich 61
Houston 55
Piscataway 53
Shanghai 51
Izmir 50
Rio de Janeiro 48
Woodbridge 48
Vienna 43
Belo Horizonte 41
Nuremberg 38
Baghdad 36
Orem 36
Frankfurt am Main 34
Tokyo 32
Chennai 29
Rome 29
Brasília 28
Guangzhou 28
Tashkent 28
Chicago 27
Dhaka 27
Phoenix 27
Porto Alegre 27
Warsaw 27
Dallas 26
Brooklyn 25
Johannesburg 25
Montreal 25
Council Bluffs 24
Curitiba 24
Guayaquil 24
Haiphong 24
Santiago 23
Denver 22
Turku 22
Campinas 21
London 21
Milan 21
Dearborn 20
Mumbai 20
Redwood City 20
Toronto 20
Istanbul 19
Jeddah 19
Lahore 19
Cape Town 18
Den Haag 18
Lima 18
Mexico City 18
Quito 18
Salvador 18
Secaucus 18
Brussels 17
Caracas 17
Frankfurt Am Main 17
Redmond 17
Manchester 16
Nairobi 16
New Delhi 16
Port Pirie 16
Amsterdam 15
Ankara 15
Boston 15
Columbus 15
Goiânia 15
Totale 18.551
Salva come PNG Salva come JPEG
Nome #
Integration of Traditional and Western Medicine in Vietnamese Populations: A Review of Health Perceptions and Therapies 171
[Metastatic gastric cancer successfully treated with surgery and chemotherapy. Case report]. 159
Anti-rheumatoid arthritis activity of decoction from the leaves of the tree Artocarpus tonkinensis used in Vietnamese traditional medicine 157
WEEKLY CARFILZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (WKCYD) FOLLOWED BY MAINTENANCE WITH WEEKLY CARFILZOMIB (WK) IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) 157
Anti-cancer activity of compounds isolated from Bursera microphylla 156
Artocarpus tonkinensis protects mice against collagen-induced arthritis and decreases Th17 cell function 154
67Ga scan detects residual active disease and it is predictive of disease-free survival in malignant lymphoma patients 152
Maesopsin 4-O-D-glucoside, a natural compound isolated from the leaves of Artocarpus tonkinensis, inhibits proliferation and up-regulates HMOX1, SRXN! and BCAS3 in acute myeloid leukemia 148
Occurrence of the same chromosome abnormalities in Ph+ and Ph- cells in chronic myeloid leukaemia. Evidence of a secondary origin of the Ph chromosome? 147
Anti-cancer activity of compounds isolated from Bursera microphylla. 142
67Ga scan detects residual active disease and it is predictive of disease-free survival in malignant lymphoma patients. 139
67Ga-SPECT/CT with a hybrid system in the clinical management of lymphoma 139
67Ga-scan detects residual active disease and it is predictive of disease-free survival in classical Hodgkin's disease patients 137
A 4-day chemosensitivity assay in vitro reliably predicts clinical response of patients with acute leukemia 129
Monitoring treatment and survival in chronic myeloid leukemia. 128
R-CHOP vs R-miniCEOP for the initial treatment of elderly “fit“ patients with diffuse large B-cell lymphoma. Results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi (IIL) 122
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned 122
Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi. 120
Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma. 120
SUMO proteins: Guardians of immune system 120
67Ga-scan usefulness in predicting the clinical outcome and the long-term effects of chemotherapy in lymphoma patients 119
A case of acute myeloid leukemia with deletion of chromosome 7 following PBSC transplantation. 117
Evaluation of response to therapy with 67Ga scintigraphy, CT scan and magnetic resonance in malignant lymphomas. 114
The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up. 113
Prognosi e terapia del mieloma multiplo. 113
Bcl-xL overexpression decreases GILZ levels and inhibits glucocorticoid-induced activation of caspase-8 and caspase-3 in mouse thymocytes 112
Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma. 111
Pharmacological modulation of caspase-8 in thymus-related medical conditions. 111
Role of microRNAs in the activity of new therapeutic inhibitors of Src kinases in CD133+ colorectal cancer cells 111
All-trans-retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phase. 111
Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patients. 110
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial. 110
A continous recurrent course in a case of nodular-sclerosis (NS) classical Hodgkin's lymphoma (cHL) associated with Castleman's disease (CD) 109
Lenalidomide and its role in the management of multiple myeloma. 108
Could thymomectomy be a reasonable option for non-myasthenic thymoma patients? 108
Antibodies binding granulocyte-macrophage colony stimulating factor produced by cord blood-derived B cell lines immortalized by Epstein-Barr virus in vitro. 107
Rare immunological presentation in B-cell chronic lymphocytic leukaemia. 106
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients 105
Fusarubin and anhydrofusarubin isolated from a Cladosporium species inhibit cell growth in human cancer cell lines 105
Alfa-interferon in the treatment of essential thrombocythemia: clinical results and evaluation of its biological effects on the hematopoietic neoplastic clone. 104
Addition of rituximabto dose-denseand high dose chemotherapy with autologous transplantation in untreated poor-prognosis diffuse large B-cell lymphoma: Results of phase II trial 104
L'interferone alfa nella leucemia mieloide cronica 103
Complex translocations of the Ph chromosome and Ph-negative CML arise from similar mechanisms as evidenced by FISH analysis. 103
Cell membrane markers and phytohemagglutinin reactivity of circulating lymphocytes from chronic myelocytic leukemia patients. 102
GM-CSF: clinical trials in non-Hodgkin's lymphoma patients with chemotherapy induced leucopenia. 102
Anagrelide in essential thrombocythemia: a retrospective analysis of 220 patients 102
La scintigrafia ossea nella diagnosi e nel "follow-up" del carcinoma mammario. 101
Isolation and identification of bioactive molecules from resins used in traditional medicine: Commiphora erythraea and Bursera microphylla 101
Osimertinib 101
The Hexane Fraction of Bursera microphylla A Gray Induces p21-Mediated Antiproliferative and Proapoptotic Effects in Human Cancer-Derived Cell Lines 100
Myelomonocytic-associated antigens in a case of genotypically, phenotypically and functionally B-cell lymphoma. 99
The role of autotransplantation in chronic lymphocytic leukemia and results from the italian group. 98
A brief course of chemo-immunotherapy FND plus rituximab is effective to induce a high clinical and molecular response in elderly patients with advanced stage follicular lymphoma (FL) at diagnosis. 98
5-Fluorouracil, vincristine and hydroxyurea combination chemotherapy in metastatic colorectal cancer. 97
Effectiveness and Safety of Combined Cytoreductive Therapy In 56 Patients With Essential Thrombocythaemia: Report of the Registro Italiano Trombocitemie (rit) 97
Indicazione all’autotrapianto in prima linea nel linfoma non-Hodgkin’s aggressivo. 95
Melphalan 200 mg/m2 versus Melphalan 100 mg/m2 in newly diagnosed myeloma patients: a prospective, multi-center phase III study. 95
Pharmacologic and immunologic effects of human leukocyte interferons in patients with neoplasia: an interim report. 95
Long term outcome of Ph plus CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era. 93
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma 93
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial. 92
Rapid and sustained response of an intra- and extracranial large cell lymphoma mass to liposomal intrathecal Ara-C and R-MegaCEOP systemic chemotherapy. 92
Phase I-II trial on natural beta interferon in chemoresistant and relapsing multiple myeloma. 92
Fattori prognostici nel carcinoma colon-retto. 92
Hydroxyurea Treatment In 1075 Patients with Essential Thrombocythemia and Occurrence of Extra-Hematological Adverse Events: A Preliminary Report of the Registro Italiano Trombocitemia (RIT) 92
Imatinib and pegylated human recombinat interferon-alpha2b in early chronic phase chronic myeloid leukaemia. 92
Pre-autologous stem cell transplantation (ASCT) treatment with rituximab does not impair stem cell harvest and engraftment in untreated patients with diffuse large B-cell lymphoma (B-DLCL) at poor prognosis 91
In vitro synergistic activity of PDN-IFN alpha and NM + IFN alpha combinations on fresh bone-marrow samples from multiple myeloma patients. 91
Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer. 91
Ph '-positive (Ph '+) chronic myeloid leukemia (CML) presenting as Ph ' plus T-lymphoblastic lymphoma (LL) resistant to high-dose chemotherapy and Gleevec. 90
Interferon Alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia. A study of 82 patients treated with intermittent administration. 90
Conventional induction treatments do not influence overall survival in multiple myeloma. 89
A continous recurrent course in a case of nodular-sclerosis (NS) classical Hodgkin's lymphoma (cHL) associated with Castleman's disease (CD) 89
R-CHOP vs R-MiniCEOP in elderly patients with diffuse large B-cell lymphoma (B-DLCL) prospectively selected by a multidimensional evaluation scale: Preliminary results of a Randomized study performed by Intergruppo Italiano Linfomi (IIL) 89
Role of caspase-8 in thymus function 89
The therapeutic effect of new Src inhibitor in colon cancer cells and potential role of mir494. 89
Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study 89
Interferon-alpha-2b as therapy for untreated and pretreated patients with Ph' positive chronic myeloid leukemia 88
Efficacy and safety of yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem cell transplantation. 88
A phase I study of human natural interferon-beta in cancer patients. 88
Chronic myeloid leukemia, BCR/ABL transcript, response to alpha-interferon and survival. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. 87
Immunologic profile in patients with Hodgkin's disease in complete remission. 86
Staging of chronic myeloid leukaemia. 86
Sustained molecular remissions are achievable with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia and additional cytogenetic clonal evolution 85
Treatment of Ph-positive Chronic Myeloid Leukemia with alpha-Interferon (Roferon-A). The Italian Cooperative Study Group experience. 85
A Phase III Study of Enoxaparin vs Aspirin vs Low-Dose Warfarin as Thromboprophylaxis for Newly Diagnosed Myeloma Patients Treated with Thalidomide Based-Regimens. 85
L’approccio terapeutico nell’anziano con mielodisplasia. 85
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage. 84
Has 67Ga-scan a role in the evaluation of lymphoma response to conventional or high dose chemotherapy? 84
Effect of adding Rituximab to intensified and high dose chemotherapy(HDC)with ASCT as first line treatment in stage III-IV at intermediate-high (IH) and high risk (HR) diffuse large B-cell lymphoma 84
Complete response correlates with long-term progression-free and overall survivals in elderly myeloma treated with novel agents: analysis of 1175 patients 84
Neutrophilic-chronic myeloid leukemia: Low levels of p230 BCR/ABL mRNA and undetectable p230 BCR/ABL protein may predict an indolent course 84
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma 84
Combination chemotherapy with 5-fluorouracil and methyl-CCNU for the treatment of advanced gastrointestinal cancer. 84
A prospective randomized trial of oral melphalan, prednisone, thalidomide (MPT) vs oral melphalan, prednisone (MP): An interim analysis. 83
Citotossicità spontanea in pazienti con B-LLC. 82
Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial. 82
A Phase Iii Study of Enoxaparin Versus Aspirin Versus Low-dose Warfarin As Thromboprophylaxis For Patients With Newly Diagnosed Multiple Myeloma Treated Up-front With Thalidomide Based-regimens 82
Has the 67Ga-SPET a role in monitoring Hodgkin and primary mediastinal lymphoma in the PET-FDG age? 81
A case of nodular sclerosis Hodgkin’s lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman’s disease: successful response to rituximab and radiotherapy. 81
Totale 10.483
Salva come PNG Salva come JPEG
Categoria #
all - tutte 165.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.636
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.589 0 696 57 123 125 55 63 1.377 39 67 385 602
2022/20235.594 512 1.044 31 395 402 609 7 253 2.147 6 151 37
2023/20241.834 137 213 107 32 20 15 555 26 80 67 244 338
2024/20254.349 47 548 89 125 569 119 102 384 1.167 357 492 350
2025/20269.911 631 670 795 1.427 890 800 1.691 639 1.210 842 218 98
2026/2027392 194 198 0 0 0 0 0 0 0 0 0 0
Totale 32.502